Clinical Trial

Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study

Study acronym: PENDOR
Recruiting
View on ClinicalTrials.gov →
Summary
This study comprises 3 stages: 1. Collection of tumor and blood samples. 2. Creation of organoid models based on tumor samples. 3. Development of functional tests to predict clinical response to treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-16; most recent amendment 2024-11-25.
Status change: Not Yet Recruiting → Recruiting 2024-11-25
Trial Details
NCT Number NCT06603506
Lead Sponsor Centre Francois Baclesse
Conditions Endometrial Cancer
Enrollment 16 participants
Start Date 2024-11-21
Primary Completion 2027-10-15 (estimated)
Study Completion 2027-10-15 (estimated)
Updated on ClinicalTrials.gov 2024-11-26